Drug maker found liable despite FDA warning label

被引：0

|

作者：

机构：

来源：

Nature | 2009年 / 458卷 / 7235期

关键词：

D O I：

10.1038/458137c

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：137 / 137

相关论文

共 50 条

[1] FDA lifts olestra warning label
Walsh, K
CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
[2] No FDA warning label for doxazosin as yet
Reactions Weekly, 2001, 856 (1) : 2 - 2
[3] Systemic ketoconazole continues to be prescribed despite an FDA warning
Muddasani, Suraj
Peck, Gabrielle
Alan, B.
Fleischer, Jr.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1787 - 1788
[4] FDA adds warning to baricitinib label: hypersensitivity
Reactions Weekly, 2020, 1814 (1) : 3 - 3
[5] FDA Warning: New Batch of Fake Bevacizumab Found
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (09): : 864 - 864
[6] FDA GROUP URGES SUX LABEL REDUCED TO WARNING
MORELL, RC
JOURNAL OF CLINICAL MONITORING, 1995, 11 (02): : 141 - 143
[7] FDA narrows drug label usage
Elie Dolgin
Nature, 2009, 460 : 1069 - 1069
[8] FDA narrows drug label usage
Dolgin, Elie
NATURE, 2009, 460 (7259) : 1069 - 1069
[9] Drug maker urges group to lobby FDA on testosterone for women
Moynihan, R
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7477): : 1255 - 1255
[10] Heartburn drug still prescribed despite FDA action
不详
GERIATRIC NURSING, 2001, 22 (04) : 178 - 178

← 1 2 3 4 5 →